Chemistry and immunoassay testing system reagents and supplies

Ended Awarded Last action

Contract number
HT941025FE032
Awardee
Awarding agency
Obligated
$31,718

Award facts

Contract value 100% obligated
$31,718.44 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Japan

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$1,647
Original award $33,365

About this award

The Defense Health Agency awarded a $31,718.44 firm fixed-price BPA call to Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global diagnostic solutions provider Ortho Clinical Diagnostics, with a completion date of September 30, 2025. This contract supports the procurement of chemistry and immunoassay testing system reagents and supplies, which are essential consumable materials for VITROS laboratory diagnostic equipment used across U.S. military medical facilities in Japan. The award represents a call against a larger Blanket Purchase Agreement valued at $875,000 and effective through June 2029, demonstrating the established relationship between the Defense Health Agency and the vendor for ongoing supply of clinical laboratory testing materials.

No socioeconomic set-aside was utilized for this award. Ortho Clinical Diagnostics K.K. has a established track record supplying laboratory reagents and diagnostic consumables to multiple U.S. military medical installations throughout the Indo-Pacific region, including naval hospitals and air force bases. The vendor's supply chain supports critical diagnostic testing operations for active duty personnel, dependents, and retirees, with the company maintaining multiple indefinite-delivery vehicles across the Department of Defense, including agreements with the Navy Bureau of Medicine and Surgery and Pacific Air Forces, positioning it as a key supplier of clinical laboratory chemistry and immunoassay testing materials for military healthcare operations in the region.

Quick answers

Who was awarded contract HT941025FE032?

HT941025FE032 was awarded to Ortho Clinical Diagnostics K.K. by Defense Health Agency (Department of Defense) on September 4, 2025.

How much is contract HT941025FE032 worth?

The government has obligated $31,718 on HT941025FE032. Its current value, with exercised options, is $31,718.

Is contract HT941025FE032 an order under another contract?

Yes. HT941025FE032 is a BPA call under HT941024A0007, a blanket purchase agreement.

Was contract HT941025FE032 competed?

The extent of competition for HT941025FE032 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award